Targeting Lifestyle Behavior Change in Adults with NAFLD During a 20-min Consultation: Summary of the Dietary and Exercise Literature

被引：31
作者：
Hallsworth K. [1 ]
Avery L. [1 ]
Trenell M.I. [1 ]
机构：
[1] Institute of Cellular Medicine, Newcastle University, MoveLab, 4th Floor William Leech Building, Newcastle upon Tyne
来源：
Current Gastroenterology Reports | 2016年 / 18卷 / 3期
基金：
英国医学研究理事会;
关键词：
Behavior change; Diet; Exercise; Non-alcoholic fatty liver disease (NAFLD); Physical activity; Weight loss;
D O I：
10.1007/s11894-016-0485-1
中图分类号：
学科分类号：
摘要：
Non-alcoholic fatty liver disease (NAFLD) is largely linked to poor diet, lack of physical activity/exercise, and being overweight. In the absence of approved pharmaceutical agents, lifestyle modification, encompassing dietary change and increased physical activity/exercise to initiate weight loss, is the recommended therapy for NAFLD. Despite this, the use of lifestyle therapy within clinical settings is lacking with limited guidance available about what it should involve, how it should be delivered, and whether it can be feasibly delivered as part of standard care. This paper highlights the evidence for the use of lifestyle modification in NAFLD. While there is evidence to support use of behavioral strategies to support lifestyle behavior change in other clinical populations, these are yet to be assessed in people with NAFLD. However, there is sufficient evidence to suggest that behavioral intervention targeting diet and physical activity to promote weight loss in general is effective and a number of practical strategies are presented on how this could be achieved. © 2016, The Author(s).
引用
收藏
页码：1 / 7
页数：6
相关论文
共 51 条
  • [1] Browning J.D., Szczepaniak L.S., Dobbins R., Nuremberg P., Horton J.D., Cohen J.C., Et al., Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity, Hepatol, 40, pp. 1387-1395, (2004)
  • [2] Smits M.M., Ioannou G.N., Boyko E.J., Utzschneider K.M., Non-alcoholic fatty liver disease as an independent manifestation of the metabolic syndrome: results of a US national survey in three ethnic groups, J Gastroenterol Hepatol, 28, pp. 664-670, (2013)
  • [3] Day C.P., Non-alcoholic fatty liver disease: current concepts and management strategies, Clin Med, J R Coll Physicians, 6, pp. 19-25, (2006)
  • [4] Matteoni C.A., Younossi Z.M., Gramlich T., Boparai N., Liu Y.C., McCullough A.J., Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity, Gastroenterol, 116, pp. 1413-1419, (1999)
  • [5] Ratziu V., Bellentani S., Cortez-Pinto H., Day C.P., Marchesini G., A position statement on NAFLD/NASH based on the EASL 2009 special conference, J Hepatol, 53, pp. 372-384, (2010)
  • [6] Loria P., Adinolfi L.E., Bellentani S., Bugianesi E., Grieco A., Fargion S., Et al., Practice guidelines for the diagnosis and management of nonalcoholic fatty liver disease: a decalogue from the Italian Association for the Study of the Liver (AISF) expert committee, Digestive and Liver Disease, 42, pp. 272-282, (2010)
  • [7] Williams R., Ashton K., Aspinall R., Bellis M., Bosanquet J., Cramp M., Et al., Implementation of the Lancet Standing Commission on Liver Disease in the UK, Lancet, 386, pp. 2098-2111, (2015)
  • [8] Thoma C., Day C.P., Trenell M.I., Lifestyle interventions for the treatment of non-alcoholic fatty liver disease in adults: a systematic review, J Hepatol, 56, pp. 255-266, (2012)
  • [9] Petersen K.F., Dufour S., Befroy D., Lehrke M., Hendler R.E., Shulman G.I., Reversal of nonalcoholic hepatic steatosis, hepatic insulin resistance, and hyperglycemia by moderate weight reduction in patients with type 2 diabetes, Diabetes, 54, pp. 603-608, (2005)
  • [10] Kirk E., Reeds D.N., Finck B.N., Mayurranjan M.S., Patterson B.W., Klein S., Dietary fat and carbohydrates differentially alter insulin sensitivity during caloric restriction, Gastroenterol, 136, pp. 1552-1560, (2009)
123456